Compare BIO-TECHNE Corp (TECH) vs Teucrium Wheat Fund (WEAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BIO-TECHNE Corp vs Teucrium Wheat Fund — how do they compare? BIO-TECHNE Corp trades at $72.13 (market cap $11.24B), while Teucrium Wheat Fund trades at $23.69. The key difference: BIO-TECHNE Corp pays a 0.44% dividend while Teucrium Wheat Fund pays none, and BIO-TECHNE Corp is trading nearer its 52-week high, Teucrium Wheat Fund nearer its low. Which is the better fit depends on your goals.
| TECH | WEAT | |
|---|---|---|
Market Cap | $11.24B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $72.29 | $26.00 |
52-Week Low | $43.31 | $19.88 |
Enterprise Value | $11.32B | — |
Dividend Yield | 0.44% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bio-Techne (TECH) trades at $72.29, up 0.54% today, with a bullish technical signal from moving averages and a consensus analyst price target of $71.67. Recent earnings showed mixed results, with a Q4 2025 beat but a Q1 2026 miss. The company maintains strong gross margins at 64.96% but faces declining net income margins, down to 6.01% in 2025. Positive cash flow trends and a pending acquisition by Merck highlight ongoing corporate developments.
Outlook is balanced with growth potential from product innovation and acquisition synergies, but risks include earnings volatility, high valuation multiples, and shareholder litigation over the merger terms. Institutional sentiment is split evenly between buy and hold ratings, reflecting cautious optimism amid execution challenges.
WEAT, the Teucrium Wheat Fund, trades at $23.91, up 0.8% on the day, with a neutral technical signal overall. Recent performance shows strength, gaining 9.9% over the past month and 25% year-to-date as of July 21, 2026 (Zacks Investment Research). Key support and resistance cluster around $24, while oscillators like the relative strength index indicate neutral momentum. The USDA's reduced wheat production outlook for 2026 to 1.56 billion bushels, below analyst expectations (WSJ, May 12, 2026), underscores supply-side influences.
Outlook remains tied to agricultural commodity cycles; inflation trends and crop forecasts drive volatility. Risks include weather disruptions and global demand shifts, but current sentiment is balanced with potential for further gains if supply constraints persist.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →About Teucrium Wheat Fund
WEAT is a commodity ETF that provides exposure to the price of wheat futures. It employs a laddered strategy across multiple benchmark contracts to mitigate the effects of contango and roll costs inherent in agricultural futures trading.
Read more on WEAT →
